Abstract: Embodiments of films, for example, infrared absorbing, heat retaining films, comprise at least one polymer selected from: a low density polyethylene (LDPE) having a density range of 0.900 g/cc to 0.930 g/cc and a melt index (I2) of 0.3 g/10 min to 2.0 g/10 min as measured in accordance with ASTM D1238; a linear low density polyethylene (LLDPE) having a density range of 0.900 g/cc to 0.930 g/cc and a melt index I2 of 0.3 g/10 min to 2.0 g/10 min; and a ethylene vinyl acetate copolymer having a vinyl acetate content ranging from 3 wt. % to 27 wt. % and a melt index I2 of 0.2 g/10 min to 10 g/10 min. The films also comprise a hybrid filler comprising (i) a layered double hydroxide, and (ii) an inorganic powder complex having a particle size distribution defined by a median diameter (D50) of 1.5 to 20 ?m.

Abstract: A functionalized MWCNT complex structure containing SiO2@EDAS nano-particles and Ag@Citrate nano-molecules and of high moisturization and sterilization includes a functionalized MWCNT; carbon atoms of a benzene of the functionalized MWCNT being combined with other functional groups containing COOH, OH and SO; a plurality of SiO2@EDAS nano-particles which are formed by modifying N-[3-(2-Aminoethylamino) propyl] trimethoxysilane (EDAS) on SiO2 nano-particles; the adhering layer further containing a plurality of Ag@Citrate nano-molecules. Therefore, since the functionalized MWCNTs 10 contains both the SiO2@EDAS nano-particles 21 and the Ag@Citrate nano-molecules 22 and thus it has the functions of the moisturization and sterilization.

Abstract: The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.

Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.

Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.

Abstract: A film comprising, consisting of, or consisting essentially of: a) a polyolefin component; b) an additive comprising i) a first polyethylene oxide/polyethylene copolymer having a HLB value in the range of from 1 to 7 and a structure selected from the group consisting of CH3CH2(CH2CH2)aCH2CH2(OCH2CH2)bOH and CH3CH2(CH2CH2)aCO(OCH2CH2)bOH wherein a is from 9 to 25 and b is from 1 to 10; and ii) a second polyethylene oxide/polyethylene copolymer having a HLB value in the range of from 7 to 18 and a structure selected from the group consisting of CH3CH2(CH2CH2)aCH2CH2(OCH2CH2)bOH and CH3CH2(CH2CH2)aCO(OCH2CH2)bOH wherein a is from 9 to 25 and b is from 1 to 10, is disclosed. The film is used in greenhouse applications.

Abstract: The present invention provides polypeptide modulators of complement activity, including cyclic polypeptide modulators. Also provided are methods of utilizing such modulators as therapeutics.

Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.

Abstract: The present invention provides polypeptide modulators of complement activity, including cyclic polypeptide modulators. Also provided are methods of utilizing such modulators as therapeutics.

Abstract: The present invention provides a visual fractional laser instrument, which comprises: an positioning cannula, the positioning cannula being a hollow tube with openings at both ends so as to locate a lesion site and define a path of the laser; a beam combiner component, the beam combiner component being a hollow tube with openings at both ends, and a side opening is provided on a side of the beam combiner component, wherein one end of the beam combiner component is connected to one end of the positioning cannula; a camera connected to the beam combiner component by the side opening to image the lesion site; a laser scanning component connected to another end of the beam combiner component for generating a laser beam used to scan the lesion site according to the image of the lesion site; and a control system connected to the laser scanning component and the camera, respectively.

Abstract: The present invention provides polypeptide modulators of complement activity, including cyclic polypeptide modulators. Also provided are methods of utilizing such modulators as therapeutics.

Abstract: The present invention discloses a root key type pressure bearing mechanism in an anchor hole, a root key type anchor cable and an anchor hole grouting method. The pressure bearing mechanism includes a carrier, root keys and a tapered plug, a through hole is formed in the center of the tapered plug, a taper hole is formed in the center of the carrier, key holes are formed along a radial direction of the carrier with an inner wall of the taper hole as a starting point, the number of the key holes is the same as that of the root keys, the root keys and the key holes constitute sliding pairs, an outer wall of the tapered plug is adapted to the taper hole, the sum of the length of the root key and the radius of a position corresponding to the tapered plug is larger than the radius of the anchor hole, and the length of the root key is less than the radius of the anchor hole; and when the tapered plug is plugged into the taper hole, the head of the root key stretches into a rock mass of the anchor hole.

Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.

Abstract: The present invention discloses a root key type pressure bearing mechanism in an anchor hole, a root key type anchor cable and an anchor hole grouting method. The pressure bearing mechanism includes a carrier, root keys and a tapered plug, a through hole is formed in the center of the tapered plug, a taper hole is formed in the center of the carrier, key holes are formed along a radial direction of the carrier with an inner wall of the taper hole as a starting point, the number of the key holes is the same as that of the root keys, the root keys and the key holes constitute sliding pairs, an outer wall of the tapered plug is adapted to the taper hole, the sum of the length of the root key and the radius of a position corresponding to the tapered plug is larger than the radius of the anchor hole, and the length of the root key is less than the radius of the anchor hole; and when the tapered plug is plugged into the taper hole, the head of the root key stretches into a rock mass of the anchor hole.

Abstract: The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.

Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.

Abstract: A portable power source and control device for a mobile phone or tablet is releasably attachable to a user's key ring or key chain and sized to be carried in a pocket or purse. The device has an internal rechargeable battery to provide emergency power for operating the user's phone, USB connectors for connection a power source and the phone, an internal microcontroller, and a Bluetooth® wireless communicator. A user actuator generated a locator command causes the phone to ring to indicate its location; and a locator command from the phone causes the device to emit a sound to indicate the device's location. The device can determine and indicate via LEDs the charge level of the battery, and has flash memory for data storage and transfer between devices.

Abstract: Systems and methods are provided for avoiding in-device coexistence interference on a user equipment. A first wireless communication circuitry and a second wireless communication circuitry operate concurrently on the user equipment. The second wireless communication circuitry detects an operational status of the first wireless communication circuitry, and determines if the operational status is transmission or reception. In response to determining that the operational status is transmission, the second wireless communication circuitry avoids receiving data. In response to determining that the operational status is reception, the second wireless communication circuitry avoids transmitting data.

Abstract: An electronic device includes a housing, an indicator plate, a circuit board, a shading case, and a guiding light member. The indicator plate is attached to an outside surface of the housing and defines a receiving hole. The circuit board is attached in the housing. The indicator light is electrically connected to the circuit board. The shading case and the circuit board together encircle the first indicator light. An end of the first shading case abuts the housing and defines a first through hole. The guiding light member is attached between the first through hole and the first receiving hole. Light emitted from the indicator light passes through the through hole to be transmitted to the receiving hole through the guiding light member.

Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.